India Supreme Court rejects Novartis' right to patent new version of cancer drug

Re:India Supreme Court rejects Novartis' right to patent new... by Alex3917 on Monday April 01, 2013 @10:41AM (#5473289)

Incorrect. It took several years to resolve, over which time the con artists at Schering-Plough (now Merck) stole several billion dollars from consumers, none of which has ever been reimbursed.

[ Parent | on HN ]

Re:India Supreme Court rejects Novartis' right to patent new... by twoodfin on Monday April 01, 2013 @11:00AM (#5473428)

Several billion dollars isn't really that much money in consumer terms. American consumers spend something like a billion dollars on scented candles each year.

Besides, it doesn't seem to me like there was much of a delay at all in getting generic loratadine to consumers:

http://www.nj.com/news/stories/0827_claritin.html

The patent expired in December 2002 and Geneva/Novartis had first-challenger exclusivity for 6 months. By August 2003, only a month or so later, the lawsuit was decided and the floodgates opened.

[ Parent | on HN ]